{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:56:44Z","timestamp":1765357004189,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.brachy.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:15:24Z","timestamp":1632269724000},"page":"1312-1322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intensity modulated high dose rate ocular brachytherapy using Se-75"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-9029","authenticated-orcid":false,"given":"Justine M","family":"Dupere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7652-0841","authenticated-orcid":false,"suffix":"III","given":"John J","family":"Munro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C","family":"Medich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2021.08.004_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-620X.94718","article-title":"Choroidal melanoma","volume":"5","author":"Singh","year":"2012","journal-title":"Oman j ophthalmol"},{"key":"10.1016\/j.brachy.2021.08.004_bib0002","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archopht.1987.01060060049030","article-title":"Selection of iodine 125 for the collaborative ocular melanoma study","volume":"105","author":"Earle","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2021.08.004_bib0003","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/jcb.2019.87407","article-title":"Complications and adverse events of plaque brachytherapy for ocular melanoma","volume":"11","author":"Peddada","year":"2019","journal-title":"J contemporary brachytherapy"},{"key":"10.1016\/j.brachy.2021.08.004_bib0004","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"key":"10.1016\/j.brachy.2021.08.004_bib0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0161-6420(99)00050-0","article-title":"Determination of surgeon's absorbed dose in iodine 125 and ruthenium 106 ophthalmic plaque surgery","volume":"107","author":"Laube","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2021.08.004_bib0006","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/sj.bjc.6602577","article-title":"Intensity-modulated radiation therapy: emerging cancer treatment technology","volume":"92","author":"Hong","year":"2005","journal-title":"Br j cancer"},{"key":"10.1016\/j.brachy.2021.08.004_bib0007","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijrobp.2019.04.009","article-title":"Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques","volume":"105","author":"Callaghan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.08.004_bib0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3103\/S0027134918030049","article-title":"Simulation of 75Se encapsulated sources for their potential use in brachytherapy","volume":"73","author":"Belousov","year":"2018","journal-title":"Moscow Univ. Phys"},{"key":"10.1016\/j.brachy.2021.08.004_bib0009","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1118\/1.3372291","article-title":"Dependence of Yb-169 absorbed dose energy correction factors on self-attenuation in source material and photon buildup in water","volume":"37","author":"Medich","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2021.08.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac02d6","article-title":"Shielded high dose rate ocular brachytherapy using Yb-169","volume":"66","author":"Dupere","year":"2021","journal-title":"Phys Med Bio"},{"key":"10.1016\/j.brachy.2021.08.004_bib0011","article-title":"Tables of x-ray mass attenuation coefficients and mass energy-absorption coefficients from 1 keV to 20 MeV for elements Z\u202f=\u202f1 to 92 and 48 additional substances of dosimetric interest","volume":"126","author":"Hubbell","year":"1996","journal-title":"NIST Standard Reference Database"},{"year":"1991","series-title":"American national standard for gamma-ray attenuation coefficients and buildup factors for engineering materials","author":"American Nuclear Society Standards Committee Working Group ANS-6.4.3","key":"10.1016\/j.brachy.2021.08.004_bib0012"},{"key":"10.1016\/j.brachy.2021.08.004_bib0013","unstructured":"Munro III JJ. Radioactive therapeutic device able to turn small radii. U.S. Patent No. 10,576,299. Washington, DC: Patent and Trademark Office 2020."},{"key":"10.1016\/j.brachy.2021.08.004_bib0014","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(99)00330-2","article-title":"A simple method of obtaining equivalent doses for use in HDR brachytherapy","volume":"46","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2021.08.004_bib0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM task group No. 43 report: a revised AAPM protocol for brachytherapy dose calculation","volume":"31","author":"Rivard","year":"2004","journal-title":"Med. Phys"},{"key":"10.1016\/j.brachy.2021.08.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1118\/1.4861715","article-title":"Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom","volume":"41","author":"Lesperance","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2021.08.004_bib0017","series-title":"Research Reports in Physics ed SM Qaim","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-58113-7_227","article-title":"Evaluated Nuclear Structure Data File (ENSDF) Nuclear Data for Science and Technology","author":"Bhat","year":"1992"},{"key":"10.1016\/j.brachy.2021.08.004_bib0018","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/rpd\/nci105","article-title":"A new human eye model for ophthalmic brachytherapy dosimetry","volume":"115","author":"Yoriyaz","year":"2005","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1016\/j.brachy.2021.08.004_bib0019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.coms.2012.08.003","article-title":"Orbital anatomy for the surgeon","volume":"24","author":"Turvey","year":"2012","journal-title":"Oral Maxillofa Surg Clin North Am"},{"key":"10.1016\/j.brachy.2021.08.004_bib0020","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med. Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121004712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472121004712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:29Z","timestamp":1761531509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472121004712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1538472121004712"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2021.08.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensity modulated high dose rate ocular brachytherapy using Se-75","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}